Immunovant, Inc.
One private offering reported to the SEC on Form D since 2016, $450.0M sold in all. Pharma, NY.
- Form D offerings: 1
- Reported sold: $450.0M
- Newest: Jan 21, 2025
Every Form D Offering
Newest first; an amended notice updates the amount sold. Each filing opens on EDGAR.| Filed | Sold | Offering | Filed as | Last amended | Filing |
|---|---|---|---|---|---|
| Jan 21, 2025 | $450.0M | $450.0M | Immunovant, Inc.Pharma ยท NY | Not amended | 0001231919-25-000012 |
SEC Profile
From the company's EDGAR record- Ticker
- IMVT
- Business address
- Durham, Nc
- Incorporated in
- DE
- SEC industry
- Biological Products, (No Diagnostic Substances)
- Former names
- Health Sciences Acquisitions Corp
- All SEC filings
- CIK 1764013 on EDGAR
A Form D reports the amount offered and sold so far in a private offering, not who invested or at what valuation. Shares issued in a merger are left out. The profile is read from EDGAR daily. SEC Form D data sets and EDGAR